跳至主要内容
临床试验/RBR-9366qc
RBR-9366qc进行中(未招募)未知

Clinical Trial Randomized, Double Blind, Placebo Controlled, of folinic acid supplementation on Endothelial Function in Individuals Infected with HIV and HIV-HCV. - FAST study: Folinic acid: Supplementation and therapy in patients with HIV and HIV-HCV infection

Fabio Lopes Pedro0 个研究点开始时间: 2014年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 49Y(—)

入选标准

  • Monoinfected patients by with HIV; or HCV-HIV co-infected; using antiretroviral therapy; who signed an consent form.

排除标准

  • history of diabetes mellitus; acute myocardial infarction; renal insufficiency (creatinine current> 1.5); stroke; clinical signs and / or laboratory evidence of liver cirrhosis (ascites, hepatic encephalopathy present or recent upper gastrointestinal bleeding, esophageal varices present, liver ultrasound with signs suggestive of cirrhosis, biopsy Metavir F4); current pregnancy; recent use (last 30 days) of: statins, fibrates, hormone replacement therapy, sulfonamides (sulfamethoxazole, sulfadiazine), vitamin supplements, or similar of folinic acid and / or folic acid; Individuals with restriction or inability to understand and decide for their participation in the study.

研究者

发起方
Fabio Lopes Pedro

相似试验

Evaluation of folinic acid supplementation, to... | 临床试验